Bausch Health Companies BHC
NYSE BHC
$6.06 -0.10 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Inventory (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Inventory came in at $1.6 billion in Q2 2026, down 3.2% year-over-year from $1.7 billion in Q2 2025, and little changed quarter-over-quarter from $1.6 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) Inventory (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Inventory across 18 years of filings, most recently posting $1.6 billion for Q2 2026.

  • In Q2 2026, Inventory fell 3.2% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (down 3.2% YoY), while the FY2025 annual figure was $1.6 billion, up 2.13% from the prior year.
  • Inventory came in at $1.6 billion for Q2 2026 at Bausch Health Companies, roughly flat from $1.6 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.7 billion in Q3 2024 to a low of $1.0 billion in Q1 2022.
  • Average Inventory over 5 years is $1.4 billion, with a median of $1.6 billion recorded in 2024.
  • Year-over-year, Inventory soared 41.65% in 2023 and fell 3.44% in 2025.
  • Over 5 years, Inventory stood at $1.1 billion in 2022, then soared by 41.65% to $1.5 billion in 2023, then climbed by 3.3% to $1.6 billion in 2024, then advanced by 2.13% to $1.6 billion in 2025, then declined by 1.66% to $1.6 billion in 2026.
  • Per Business Quant data, the three most recent Inventory figures were $1.6 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn 3.22 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn 3.93 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn 850.02 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn 677.95 Mn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn 1.60 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn 226.55 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn 143.15 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn 179.91 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn -
10 RedHill Biopharma 171.02 Mn 171.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Bn
Mar 31, 2026 1.60 Bn
Dec 31, 2025 1.63 Bn
Sep 30, 2025 1.60 Bn
Jun 30, 2025 1.66 Bn
Mar 31, 2025 1.61 Bn
Dec 31, 2024 1.60 Bn
Sep 30, 2024 1.66 Bn
Jun 30, 2024 1.61 Bn
Mar 31, 2024 1.64 Bn
Dec 31, 2023 1.54 Bn
Sep 30, 2023 1.27 Bn
Jun 30, 2023 1.24 Bn
Mar 31, 2023 1.22 Bn
Dec 31, 2022 1.09 Bn
Sep 30, 2022 1.06 Bn
Jun 30, 2022 1.07 Bn
Mar 31, 2022 1.05 Bn
Dec 31, 2021 993.00 Mn
Sep 30, 2021 1.06 Bn